HSPG2 and breast cancer: PC-PLC activity may also be upregulated in tumourigenic prostate lines (Figure 11), as detected in ovarian and breast cancer cells (Glunde et al, 2004; Iorio et al, 2005, 2010), further increasing PCho formation.